Bausch + Lomb Corporation
General ticker "BLCO" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $5.5B (TTM average)
Bausch + Lomb Corporation follows the US Stock Market performance with the rate: 33.3%.
Estimated limits based on current volatility of 1.8%: low 17.39$, high 18.02$
Factors to consider:
- Total employees count: 13000 (-3.7%) as of 2025
- Top business risk factors: Economic downturns and volatility, Inflation impact, Separation success uncertainties, Market competition, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [15.38$, 23.73$]
- 2026-12-31 to 2027-12-31 estimated range: [15.80$, 24.57$]
Financial Metrics affecting the BLCO estimates:
- Positive: with PPE of 34.1 at the end of fiscal year the price was low
- Positive: -4.23 < Operating profit margin, % of 2.25
- Negative: Interest expense per share per price, % of 6.97 > 3.34
- Positive: 0.28 < Operating cash flow per share per price, % of 4.69
- Negative: Industry operating cash flow per share per price (median), % of 1.58 <= 5.56
- Positive: Inventory ratio change, % of -1.65 <= -0.75
- Positive: 42.26 < Shareholder equity ratio, % of 45.98 <= 63.63
Short-term BLCO quotes
Long-term BLCO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $4,072.00MM | $4,747.00MM | $5,026.00MM |
| Operating Expenses | $3,942.00MM | $4,585.00MM | $4,913.00MM |
| Operating Income | $130.00MM | $162.00MM | $113.00MM |
| Non-Operating Income | $-296.00MM | $-396.00MM | $-430.00MM |
| Interest Expense | $283.00MM | $399.00MM | $421.00MM |
| R&D Expense | $324.00MM | $343.00MM | $371.00MM |
| Income(Loss) | $-166.00MM | $-234.00MM | $-317.00MM |
| Taxes | $82.00MM | $71.00MM | $35.00MM |
| Net Income(Loss)* | $-260.00MM | $-317.00MM | $-360.00MM |
| Stockholders Equity | $6,850.00MM | $6,473.00MM | $6,448.00MM |
| Inventory | $1,028.00MM | $1,036.00MM | $976.00MM |
| Assets | $13,442.00MM | $13,469.00MM | $14,022.00MM |
| Operating Cash Flow | $-17.00MM | $232.00MM | $283.00MM |
| Capital expenditure | $181.00MM | $291.00MM | $349.00MM |
| Investing Cash Flow | $-2,109.00MM | $-412.00MM | $-455.00MM |
| Financing Cash Flow | $2,078.00MM | $178.00MM | $225.00MM |
| Earnings Per Share** | $-0.74 | $-0.90 | $-1.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.